# ai.rxmanager/mcp

> Live US drug acquisition costs (CMS NADAC) for AI assistants. Free, no auth, weekly data.

- name: ai.rxmanager/mcp
- version: 0.1.0
- connection class: R0 (autonomous)
- trust: 75/100 flags: no-repository
- quality: 79/100 (good)
- owner: not claimed
- descriptor: https://api.protogrid.dev/v1/servers/ai.rxmanager%2Fmcp
- tools: https://api.protogrid.dev/v1/servers/ai.rxmanager%2Fmcp/tools

**An agent can connect right now, no human step.** Remote endpoint, no authentication, reachable on the last probe.

## Connection (mcpServers)

```json
{
  "mcpServers": {
    "rxmanager": {
      "type": "http",
      "url": "https://mcp.rxmanager.ai/mcp"
    }
  }
}
```


## Trust

- hygiene: 80
- liveness: 99
- freshness: 65
- provenance: 55
- drivers: +dns-namespace +website +reachable +uptime-97% ~updated-131d-ago -no-repository
- Derived from observable signals (official registry feed and our own credential-free probes); no code audit performed.

## Quality 79/100 (good)

### protocol: 75 (weight 25)

- warn `protocol.modern`: newest supported version is 2025-03-26; 2026-07-28 not supported, older versions are deprecated until 2027-07-28
- n/a `protocol.stateless`: only applies to 2026-07-28 servers
- pass `protocol.transport`: streamable HTTP
- n/a `protocol.list_ttl`: only applies to 2026-07-28 servers

### authorization: n/a (weight 15)

- n/a `auth.prm`, `auth.as_metadata`, `auth.cimd`: no remote uses OAuth
- n/a `auth.secret_in_url`: no templated URL

### tool hygiene: 71 (weight 30)

- pass `tools.descriptions`: every tool has a description
- pass `tools.description_length`: descriptions are concise
- pass `tools.schemas`: every tool has an object input schema
- fail `tools.annotations`: no tool declares readOnlyHint or destructiveHint, so clients cannot tell safe calls from risky ones
- fail `tools.directory_hints`: no tool declares all four of readOnlyHint, destructiveHint, idempotentHint and openWorldHint; missing: drug_search (readOnlyHint, destructiveHint, idempotentHint, openWorldHint); drug_spread_check (readOnlyHint, destructiveHint, idempotentHint, openWorldHint); drug_shortages (readOnlyHint, destructiveHint, idempotentHint, openWorldHint); …
- pass `tools.token_cost`: about 1,100 tokens to load every tool
- pass `tools.api_dump`: tools are not a one-to-one API dump

### stability: 100 (weight 15)

- pass `stability.changes`: no tool changes in 30 days
- pass `stability.rug_pull`: no tool changed its meaning under the same name

### dependencies: n/a (weight 15)

- n/a `deps.known_vulns`, `deps.mcp_sdk_version`, `deps.resolvable`: no npm or PyPI package

- tools: 8, about 1,100 tokens to load them all
- tool set hash: f300bc6db76175c0934f38dde03cc53a
- badge: [![protogrid quality](https://protogrid.dev/badge/ai.rxmanager/mcp.svg)](https://protogrid.dev/servers/ai.rxmanager/mcp)
- Checks run on what our credential-free, read-only probes observe; tools are never called and no code audit is performed.

### Tool changes

_No tool definition changes recorded._

## Remotes

- https://mcp.rxmanager.ai/mcp (streamable-http, auth none, reachable true, uptime30d 0.9741379)

## Packages

_none_

## Tools (8)

- `drug_info_lookup`: Full profile of a US prescription drug by brand or generic name: identity and manufacturer, live CMS NADAC acquisition pricing, Medicare Part D spending and utilization, estimated pricing spread, and active clinical-trial pipeline. Broader than drug_price_lookup — use when someone wants the whole picture of a drug.
- `drug_price_lookup`: Look up the live public acquisition cost (CMS NADAC — National Average Drug Acquisition Cost) for a prescription drug in the United States: the per-unit price retail pharmacies actually pay to buy it, by strength, with the effective date. This is the honest baseline for judging what an employer health plan is charged by its PBM. Accepts a brand or generic name (e.g. "Gleevec", "imatinib", "atorvastatin").
- `drug_search`: Search US prescription drugs by full or partial brand/generic name. Returns matching drugs with their generic name and brand names, so you can pick the right one before calling drug_price_lookup or drug_spread_check.
- `drug_shortages`: List current US prescription drug shortages from the FDA Drug Shortage Database (refreshed daily). Optionally filter by drug name or drug class. Returns the generic name, brand names, how long the shortage has been running, and how many manufacturers are affected. Useful for checking whether a drug a plan or patient depends on is in shortage before a refill or formulary decision.
- `drug_spread_check`: Compare what a US health plan was actually charged for a prescription fill against the live public acquisition cost (CMS NADAC) for the same quantity. Returns the acquisition cost, the amount charged, the gap, and the multiple. Use when someone asks "my plan paid $X for [drug] — is that high?". The gap is not all margin (a dispensing fee and claim administration are legitimate), but on most generics the legitimate part is a few dollars, not hundreds.
- `medical_code_lookup`: Look up any US medical claim code across all major code sets at once: CPT (with 2025 RVUs), ICD-10-CM diagnoses, HCPCS Level II, MS-DRG payment groups, CARC denial reason codes (accepts EOB formats like CO-45 or PR-1), and place-of-service codes — plus Medicare MUE unit limits and NCCI bundling-edit counts. Official CMS/CDC/X12 data. Use when someone has a code from a medical bill, claim, EOB, or denial letter.
- `pbm_term_explainer`: Plain-English explanation of pharmacy benefit (PBM) contract terms that drive employer plan cost: spread pricing, pass-through pricing, AWP, WAC, NADAC, MAC, rebates, rebate pass-through, effective rate guarantees, lesser-of logic, DIR fees, audit rights. Each explanation includes what to watch for in a contract. Call with a specific term, or without one to list all terms.
- `renewal_checklist`: Generate a dated preparation checklist for an employer pharmacy-benefit (PBM) contract renewal. Given the renewal date, returns what a plan sponsor should request and do at 120, 90, 60, and 30 days out — contract and exhibits, claims data, rebate reconciliation, benchmark review, and the decision record. Deterministic and vendor-neutral.